Skip to nav Skip to content

CDC/IDSA COVID-19 Clinician Call: Beyond Acute SARS-CoV-2 Infection: Clinical Definitions and Considerations

Facebook Twitter LinkedIn Email

To Download a copy of the presentation click here.

*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number 6 NU50CK000477-04-01). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.

These one-hour webinars, held Saturdays at 3 p.m. ET, focus on timely issues of relevance to clinicians and feature case presentations by experts in the field, synthesis of new data, and an opportunity to engage with colleagues. Register for next week here.


  • Dana S. Wollins, DrPH, MGC
    Vice President, Clinical Affairs & Practice Guidelines, IDSA

Featured Speakers and Presentations:

  • A Framework and Timeline of the Clinical Spectrum of Disease due to SARS CoV-2 Infection

    S. Deblina Datta, M.D., FIDSA
    Lead, Clinical Team
    Health Systems and Worker Safety Task Force
    COVID-19 Emergency Operations Center
    Centers for Disease Control and Prevention

  • Experiences from a Dedicated Post COVID Care Clinic, Mount Sinai Hospital, NY

    Juan Wisnivesky, M.D., DrPH
    Drs. Richard and Mortimer Bader Professor of Medicine
    Chief, Division of General Internal Medicine
    Icahn School of Medicine at Mount Sinai

  • Investigative Criteria

  • Common Investigative Protocol

Latest Media

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.